SCHEMBL28126238

SCHEMBL28126238

Cc1ccc(S(=O)(=O)O[C@H]2CCN(OC(=O)C(C)(C)C)C2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 2/20 0.55
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.38
CYP2C19 P33261 1/20 0.38
ALDH1A1 P00352 6/20 0.37
KMT2A Q03164 4/20 0.37
USP2 O75604 2/20 0.37
ALOX15 P16050 1/20 0.37
TSHR P16473 1/20 0.37
HTT P42858 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
MCOLN3 Q8TDD5 1/20 0.37
MAPT P10636 1/20 0.37
HPGD P15428 1/20 0.37
RAB9A P51151 2/20 0.36
MEN1 O00255 1/20 0.36
SCN1A P35498 1/20 0.36
SCN2A Q99250 1/20 0.36
SCN3A Q9NY46 1/20 0.36
MMP13 P45452 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28555962 0.94 CYP2D6 (0.49) CYP2D6CYP1A2CYP3A4CYP2C19ALDH1A1
SCHEMBL27927598 0.93 CYP2D6 (0.61) CYP2D6CYP1A2CYP3A4CYP2C19ALDH1A1
SCHEMBL27988941 0.91 CYP2D6 (0.49) CYP2D6CYP1A2CYP3A4CYP2C19ALDH1A1
SCHEMBL208706 0.82 CYP2D6 (0.57) CYP2D6CYP1A2CYP3A4CYP2C19ALDH1A1
SCHEMBL28106795 0.81 ALDH1A1 (0.40) CYP2D6CYP1A2ALDH1A1KMT2AUSP2
SCHEMBL28237166 0.80 EPHX2 (0.42) SCN1ASCN2ASCN3A
SCHEMBL221064 0.80 CYP2D6 (0.54) CYP2D6CYP1A2KMT2AMEN1MMP13
SCHEMBL222877 0.80 CYP2D6 (0.54) CYP2D6CYP1A2KMT2AMEN1MMP13
SCHEMBL221063 0.80 CYP2D6 (0.54) CYP2D6CYP1A2KMT2AMEN1MMP13
SCHEMBL28795040 0.78 CYP2D6 (0.38) CYP2D6CYP1A2CYP3A4CYP2C19ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106459002-A Biaryl compounds useful in the treatment of human oncological, neurological and immunological diseases 比奥根MA公司 2017-02-22 CN disclosed